May 30, 2019

Can Exercise Alter Parkinson Disease Progression? NIH Award Launches First Long-Term Study to Find Out

Study to assess effects of 12 months of home-based cycling

650×450-Stationery-Bike-Parkinsons

The National Institutes of Health (NIH) has awarded Cleveland Clinic researcher Jay Alberts, PhD, a five-year, $3 million grant to conduct a two-site clinical trial to assess potential disease-altering effects of long-term, high-intensity, home-based aerobic exercise in Parkinson disease (PD).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Effective disease-modifying therapy for patients with PD remains elusive,” says Dr. Alberts, Vice Chair of Innovation in Cleveland Clinic’s Neurological Institute and a staff member in the Department of Biomedical Engineering. “Exercise is accepted as adjunctive treatment for PD, but its disease-altering properties are unclear. The work funded by this award will be the first long-term investigation of the potential for aerobic exercise to arrest disease progression.”

Building on prior work

High-intensity exercise has been shown to yield neuroprotective effects and improve motor functioning in animal models of PD. Moreover, Dr. Alberts’ group has reported promising translational work in humans with PD, leading up to the recently completed 100-subject CYCLE trial (CYClical Lower Extremity Exercise for Parkinson’s; NCT01636297), which also was supported by the NIH.

Results of that study, for which Dr. Alberts served as principal investigator, showed that eight weeks of aerobic exercise on a stationary recumbent bicycle in a controlled laboratory setting significantly improved global motor function and specific aspects of gait and cognitive function in individuals with PD. Results in the full 100-patient cohort were presented in a May 29 platform presentation at the 2019 Annual Meeting of the American College of Sports Medicine. Results in a subset of 59 patients were published online by the Journal of the Neurological Sciences earlier this year, showing that eight weeks of high-intensity aerobic training significantly enhanced overall functional mobility.

Advertisement

“These positive outcomes provide a strong rationale for studying the effectiveness of a long-term CYCLE protocol in a home-based setting to impact a greater number of people with PD,” Dr. Alberts explains. “In addition to exploring whether exercise can slow disease progression, our new study aims to assess how well this laboratory-based protocol is translated to patients’ homes.”

250 patients randomized to 12 months of exercise or usual care

For the new study, Cleveland Clinic and University of Utah researchers will recruit 250 individuals with PD and randomize them to either high-intensity home exercise or usual and customary care (UCC). Patients in the exercise group will use indoor cycling bikes from the fitness technology company Peloton and follow the CYCLE trial’s exercise protocol three times a week for 12 months. Patients in the UCC group will be instructed to engage in their normal activities.

The two groups will undergo identical blinded motor and non-motor evaluation protocols at enrollment and at six and 12 months. In addition to assessment with the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III, patients will have motor and non-motor skills systematically quantified via the PD Performance Test, a validated collection of biomechanical-based iPad applications developed in Dr. Alberts’ lab. Overall activity levels will be monitored for both groups via a wearable sensor.

Advertisement

In search of a predictive model

“Combining clinical and biomechanical measures of motor and cognitive function will accelerate our understanding of potential mechanisms underlying positive effects of exercise on disease progression,” Dr. Alberts explains.

He adds that exercise performance data will be gathered to monitor exercise adherence and to build an exercise response predictive model. “We hope the model will facilitate a transition from general recommendations to patient-specific exercise prescriptions for which potential outcomes can be estimated,” he concludes.

Related Articles

22-NEU-2959102-CQD-Hero-650×450
June 15, 2022
MINDS Study Will Assess Lifestyle Interventions for Slowing Brain Pathology in Preclinical Stages

New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study

22-NEU-2671014-CQD-650×450-Type
March 9, 2022
A Closer Look at the Cleveland Clinic Brain Study

How the new longitudinal investigation could become the Framingham Heart Study of brain health

20-NEU-1959738 powered-exoskeleton-for-gait-training_650x450
October 23, 2020
Study Signals Potential of Powered Exoskeleton for Gait Training in Multiple Sclerosis

Pilot findings show good patient acceptance and safety, early hints of efficacy

20-NEU-1990660-sleep-symptoms-in-health-workers-650×450
October 21, 2020
Electronic Screening for Sleep Disorders Among Healthcare Workers Is Feasible – and Sorely Needed

Study finds high prevalence of symptoms, willingness to seek treatment

20-NEU-1946228 neurofilaments_650x450
September 9, 2020
Serum Neurofilament Light as a Progressive MS Biomarker: Guideposts for the Road Ahead

Panel outlines research priorities around a promising alternative to imaging markers

20-NEU-1951118_Impella-temporary-LVAD_650x450_ (1)
September 4, 2020
Study Finds Clues to Acute Neurologic Events With Short-Term Impella Cardiac Support

Suspected factors include antithrombotic intensity, time on device, presence of thrombocytopenia

20-NEU-1929179 deep-brain-stimulation-for-TBI_650x450
September 3, 2020
Could DBS of the Cerebellar Dentate Nucleus Enhance Post-TBI Rehabilitation?

Preclinical studies will assess whether method developed for stroke recovery curbs deficits after brain injury

20-NEU-1932968-sleep-apnea-in-women_650x450
August 12, 2020
Is Upper Airway Stimulation for OSA Being Denied to Many Patients Who Can Benefit Most?

Study finds high coverage denial for women, patients with prior oral appliance use

Ad